5 completed, 4 unknown, 1 terminated, 1 withdrawn. 11 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 5, Unknown 4, Terminated 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow genexol-PM: new trials by email Literature Review of genexol-PM trials Research Report on genexol-PM
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 Paclitaxel, mFOLFOX6 regimen - Gastric Cancer Stage IV, Peritoneal Carcinomatosis | Phase 1 / Phase 2 | Completed | Seoul National University Bundang Hospital | 35 | 2018-12-24 | 2023-12-05 |
| Paclitaxel-Avelumab for Angiosarcoma Avelumab, Paclitaxel - Angiosarcoma Metastatic | Phase 2 | Unknown | Sung Yong Oh | 32 | 2018-06-01 | 2018-07-11 |
| A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib Genexol-PM - Carcinoma, Hepatocellular | Phase 2 | Terminated | Gachon University Gil Medical Center | 5 | 2016-10-01 | 2021-02-04 |
| Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas Genexol-PM, Gemcitabine - Recurrent Adenocarcinoma of the Pancreas, Metastatic Adenocarcinoma of the Pancreas | Phase 2 | Unknown | Samyang Biopharmaceuticals Corporation | 47 | 2016-04-01 | 2018-04-18 |
| Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer Paclitaxel, Eribulin, Gemcitabine - Metastatic Breast Cancer | Phase 2 | Completed | Asan Medical Center | 118 | 2014-12-19 | 2020-07-14 |
| A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer Doxorubicin/Genexol-PM - Metastatic Breast Cancer | Phase 2 | Unknown | Gachon University Gil Medical Center | 48 | 2011-01-01 | 2016-02-10 |
| A Trial of Paclitaxel (Genexol®) and Cisplatin Versus Paclitaxel Loaded Polymeric Micelle (Genexol-PM®) and Cisplatin in Advanced Non Small Cell Lung Cancer Paclitaxel (Genexol®), Paclitaxel loaded polymeric micelle (Genexol-PM®) - Non Small Cell Lung Cancer | Phase 2 | Completed | Samyang Biopharmaceuticals Corporation | 276 | 2008-06-01 | 2017-05-09 |
| Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer carboplatin, paclitaxel-loaded polymeric micelle - Ovarian Cancer | Phase 1 / Phase 2 | Unknown | Asan Medical Center | 74 | 2008-05-01 | 2013-08-02 |
| Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum Genexol PM - Bladder Cancer, Ureter Cancer | Phase 2 | Completed | Asan Medical Center | 37 | 2007-12-01 | 2011-12-07 |
| Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients Genexol-PM, Paclitaxel - Breast Cancer | Phase 2 | Withdrawn | National Cancer Center, Korea | 2007-07-01 | 2012-01-04 | |
| Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer paclitaxel-loaded polymeric micelle - Pancreatic Cancer | Phase 2 | Completed | Theradex | 43 | 2005-05-01 | 2011-12-14 |
Breast Neoplasms (3) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Ovarian Epithelial (1) · Carcinoma, Transitional Cell (1) · Digestive System Neoplasms (1) · Hemangiosarcoma (1) · Liver Diseases (1) · Liver Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms by Site (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Peritoneal Neoplasms (1) · Recurrence (1)
Asan Medical Center (3) · Gachon University Gil Medical Center (2) · Samyang Biopharmaceuticals Corporation (2) · National Cancer Center, Korea (1) · Seoul National University Bundang Hospital (1) · Sung Yong Oh (1) · Theradex (1)
South Korea (9) · United States (1)
Dong Bok Shin, Professor (1) · Hyun Woo Lee, M.D. (1) · Hyung-Ho Kim, M.D., PhD. (1) · Jae-Lyun Lee, M.D., Ph.D. (1) · John S. MacDonald, MD (1) · Jungsil Ro, Ph,D (1) · Kyung Hae Jung, Dr (1) · Sun Young Kim, Ph.D. (1) · Yong Man Kim, MD, PhD (1)